Navigation Links
ISTO Technologies to Present at OneMedPlace Finance Forum
Date:12/20/2007

ST. LOUIS, Dec. 20 /PRNewswire/ -- ISTO Technologies, Inc., a privately held orthobiologic company, announced today that it will participate in the OneMedPlace Finance Forum in San Francisco, CA from January 7-8, 2008. Mitchell Seyedin, Ph. D., President and CEO of ISTO, will present on Tuesday, January 8th at 11:00 a.m. Pacific Time, at the Sir Francis Drake Hotel at 450 Powell St. Information about the OneMedPlace Finance Forum may be found at http://www.onemedplace.com.

ISTO's rich product pipeline includes DeNovo(R) ET, a tissue engineered cartilage implant in Phase I/II trials for resurfacing knee joints, NuQu(TM), a cartilage cell-based product in late-stage development for degenerated disc nucleus, and InQu(R), a biomaterial for bone regeneration that has received 510(k) clearance. ISTO's innovative products are designed to address very large markets with unmet clinical needs.

Cartilage regeneration is often called the "holy grail" of the orthopedic industry because of its potential to restore function to damaged joints that otherwise have limited healing potential. Cartilage serves as a "shock absorber" protecting all joints, including spinal discs, from the wear and tear experienced during motion.

InQu represents a new class of biomaterial designed to offer a number of clinical advantages to surgeons and patients.

About ISTO

ISTO Technologies, Inc. is developing and marketing clinical solutions for sports medicine, spinal therapy, and trauma. ISTO's products are intended for the repair and regeneration of damaged or injured cartilage and bone. For additional information on ISTO, please visit our website at http://www.istotech.com or contact the Company at 314-995-6049.


'/>"/>
SOURCE ISTO Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Calif. , April 21, 2015 /PRNewswire/ ... provider of advanced cryogenic logistics solutions for ... immunotherapies, stem cells, cell lines, clinical research ... announced that Dr. Mark W. Sawicki ... the 3rd Annual BioLogistics Summit in ...
(Date:4/21/2015)... SYDNEY , April 21, 2015  Novogen Limited ... Australian/US biotechnology company, advises that it has entered ... million fully-paid ordinary shares plus one attaching 6-month ... for every ordinary share issued, to institutional investors ... in a private placement for aggregate gross proceeds ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Progyny, Inc., ... Authority, LLC, announced that it has secured additional capital ... TPG Biotech, SR One and Merck Serono Ventures. The ... provide patients the best fertility outcomes by aligning science, ... largest online marketplace for families seeking fertility solutions and ...
(Date:4/21/2015)... DIEGO, CA (PRWEB) April 21, 2015 Whether ... in a lab, or bolted to a Kessler CineDrive ... stadium… or at the beach, the TS3-H is designed to ... Based on a brand-new state-of-the-art 5MP sensor, the TS5-H offers ... predecessors, with superior imaging characteristics. , According to Tom ...
Breaking Biology Technology:Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 3Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 5Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 6Announcing Progyny: Combining Best-in-Class Clinical Solutions with Consumer Expertise 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 3
...  AMPAC Fine Chemicals LLC (AFC), a wholly-owned ... has concluded an agreement with Chimerix, Inc. to validate ... in Chimerix,s broad spectrum antiviral drug candidate, CMX001, which ... smallpox.  Chimerix will provide the investigational drug product under ...
... FORT LEE, N.J., Aug. 11, 2011 Neurologix, ... of innovative gene therapies for disorders of the brain and ... three and six months ended June 30, 2011. ... a net loss of approximately $3.0 million, as compared with ...
... Genetics, Inc. (OTCQB: ILIU) announced today that CEO Lewis ... Management Access Conference at the Le Parker Meridien Hotel, 119 ... scheduled for Wednesday, Aug. 17 at 3:35 p.m. (EDT) in ... Interleukin,s management team will be available for one-on-one meetings ...
Cached Biology Technology:AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API 2AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API 3AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API 4Neurologix Announces Second Quarter 2011 Financial Results 2Neurologix Announces Second Quarter 2011 Financial Results 3Neurologix Announces Second Quarter 2011 Financial Results 4Neurologix Announces Second Quarter 2011 Financial Results 5Neurologix Announces Second Quarter 2011 Financial Results 6Neurologix Announces Second Quarter 2011 Financial Results 7Neurologix Announces Second Quarter 2011 Financial Results 8Interleukin Genetics, Inc. to Present at the 2011 Wedbush Securities Life Sciences Management Access Conference 2
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced ... Strategic Business Report" report to their offering. This ... US$ Thousands by the following Segments: Face Biometrics, and Voice Biometrics. ... Canada , Japan , Europe ... & Africa , and ...
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for ...
Breaking Biology News(10 mins):Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... a group of plant viruses that cause devastating disease ... with The American Phytopathological Society (APS). , According ... University of Arizona's Department of Plant Sciences, the whitefly, ... (transmitter) for a large group of emerging plant viruses ...
... around the world die of this type of meningitis, according ... the disease is called, can even spark epidemics: in Africa ... the late 1990s. Without treatment, mortality among those who ... percent. Patients also run a high risk of serious ...
... But exactly what our tears are made of has remained a ... the complex design of tears. What we think of as tears, ... microscopic layers. The middle, watery layer ?what we normally think of ... mucus and an outer layer of fatty, oily substances collectively called ...
Cached Biology News:Tears reveal some of their deepest secrets to researchers 2Tears reveal some of their deepest secrets to researchers 3
Reacts with methylated DNA from plants and vertebrates...
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
WTAP Antibody...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
Biology Products: